784 related articles for article (PubMed ID: 14601692)
21. A patient with mixed type Evans syndrome: efficacy of rituximab treatment.
Park CY; Chung CH
J Korean Med Sci; 2006 Dec; 21(6):1115-6. PubMed ID: 17179698
[TBL] [Abstract][Full Text] [Related]
22. Rituximab for refractory Evans syndrome and other immune-mediated hematologic diseases.
Mantadakis E; Danilatou V; Stiakaki E; Kalmanti M
Am J Hematol; 2004 Nov; 77(3):303-10. PubMed ID: 15495242
[TBL] [Abstract][Full Text] [Related]
23. Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 16 cases.
Dufour JF; Pradat P; Ruivard M; Hot A; Dumontet C; Broussolle C; Trepo C; Sève P
Eur J Gastroenterol Hepatol; 2009 Mar; 21(3):245-53. PubMed ID: 19279468
[TBL] [Abstract][Full Text] [Related]
24. Maintenence rituximab following induction in autoimmune cytopenias.
Rai MP; Lee EJ; Bussel JB
Br J Haematol; 2023 Jul; 202(1):153-158. PubMed ID: 37086173
[TBL] [Abstract][Full Text] [Related]
25. [Clinical therapeutic efficacy of rituximab for relapsed and refractory idiopathic thrombocytopenic purpura].
Zhou LY; Zhang Z; Song LX; Gzhang X; Su JY; Li X; Chang CK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):941-4. PubMed ID: 22931660
[TBL] [Abstract][Full Text] [Related]
26. [The long-term efficacy and safety of rituximab combined with cyclophosphamide in treatment of seven patients with refractory and recurrent autoimmune hemolytic anemia].
Liu H; Xing LM; Wang HQ; Wu YH; Qu W; Liang Y; Wang GJ; Song J; Wang XM; Guan J; Li LJ; Fu R; Shao ZH
Zhonghua Nei Ke Za Zhi; 2012 Jun; 51(6):456-9. PubMed ID: 22943757
[TBL] [Abstract][Full Text] [Related]
27. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
[TBL] [Abstract][Full Text] [Related]
28. The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura.
Cooper N; Stasi R; Cunningham-Rundles S; Feuerstein MA; Leonard JP; Amadori S; Bussel JB
Br J Haematol; 2004 Apr; 125(2):232-9. PubMed ID: 15059147
[TBL] [Abstract][Full Text] [Related]
29. Vincristine-loaded platelet infusion for treatment of refractory autoimmune hemolytic anemia and chronic immune thrombocytopenia: rethinking old cures.
Shvidel L; Sigler E; Shtalrid M; Berrebi A
Am J Hematol; 2006 Jun; 81(6):423-5. PubMed ID: 16680744
[TBL] [Abstract][Full Text] [Related]
30. Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results.
Medeot M; Zaja F; Vianelli N; Battista M; Baccarani M; Patriarca F; Soldano F; Isola M; De Luca S; Fanin R
Eur J Haematol; 2008 Sep; 81(3):165-9. PubMed ID: 18510702
[TBL] [Abstract][Full Text] [Related]
31. [Recurrent infections in an ITP patient treated with rituximab].
Rosenberg-Bezalel S; Asher I; Sthoeger Z
Harefuah; 2012 Nov; 151(11):617-9, 655. PubMed ID: 23367730
[TBL] [Abstract][Full Text] [Related]
32. Rituximab therapy for childhood Evans syndrome.
Bader-Meunier B; Aladjidi N; Bellmann F; Monpoux F; Nelken B; Robert A; Armari-Alla C; Picard C; Ledeist F; Munzer M; Yacouben K; Bertrand Y; Pariente A; Chaussé A; Perel Y; Leverger G
Haematologica; 2007 Dec; 92(12):1691-4. PubMed ID: 18055994
[TBL] [Abstract][Full Text] [Related]
33. Rituximab for warm-type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patients.
D'Arena G; Califano C; Annunziata M; Tartarone A; Capalbo S; Villani O; Amendola G; Pietrantuono G; Ferrara F; Pinto A; Musto P; D'Arco AM; Cascavilla N
Eur J Haematol; 2007 Jul; 79(1):53-8. PubMed ID: 17532766
[TBL] [Abstract][Full Text] [Related]
34. Targeted ITP strategies: do they elucidate the biology of ITP and related disorders?
Bennett CM; de Jong JL; Neufeld EJ
Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):706-9. PubMed ID: 16933263
[TBL] [Abstract][Full Text] [Related]
35. Evans syndrome. Results of a pilot study utilizing a multiagent treatment protocol.
Scaradavou A; Bussel J
J Pediatr Hematol Oncol; 1995 Nov; 17(4):290-5. PubMed ID: 7583383
[TBL] [Abstract][Full Text] [Related]
36. Rituximab for the treatment of acute refractory ITP.
Kim SG; Whyte D; Pashankar FD
J Pediatr Hematol Oncol; 2014 Apr; 36(3):e149-51. PubMed ID: 23669737
[TBL] [Abstract][Full Text] [Related]
37. Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults.
Provan D; Butler T; Evangelista ML; Amadori S; Newland AC; Stasi R
Haematologica; 2007 Dec; 92(12):1695-8. PubMed ID: 18055995
[TBL] [Abstract][Full Text] [Related]
38. A combination of rituximab, cyclophosphamide and dexamethasone effectively treats immune cytopenias of chronic lymphocytic leukemia.
Kaufman M; Limaye SA; Driscoll N; Johnson C; Caramanica A; Lebowicz Y; Patel D; Kohn N; Rai K
Leuk Lymphoma; 2009 Jun; 50(6):892-9. PubMed ID: 19391041
[TBL] [Abstract][Full Text] [Related]
39. Presence of Idiopathic Thrombocytopenic Purpura and autoimmune hemolytic anemia in the patients with common variable immunodeficiency.
Ramyar A; Aghamohammadi A; Moazzami K; Rezaei N; Yeganeh M; Cheraghi T; Pouladi N; Heydari G; Abolhassani H; Amirzargar AA; Parvaneh N; Moin M
Iran J Allergy Asthma Immunol; 2008 Sep; 7(3):169-75. PubMed ID: 18780952
[TBL] [Abstract][Full Text] [Related]
40. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH
Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
